Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 25, 2014
Dyspnea and reversibility profile of P2Y₁₂ antagonists: systematic review of new antiplatelet drugsDaniel Caldeira, Fausto J Pinto, Joaquim J Ferreira
Heliyon|November 25, 2024
Risk of infective endocarditis in patients with mitral valve prolapse: Systematic review with meta-analysisLuisa Marques, Catarina de Sousa, Fausto J Pinto, et al.
Expert Opinion on Drug Safety|March 10, 2016
Safety of non-vitamin K antagonist oral anticoagulants - coronary risksDaniel Caldeira, Joaquim J Ferreira, Fausto J Pinto, et al.
Scientific Reports|January 26, 2024
The association between asthma and atrial fibrillation: systematic review and meta-analysisBeatriz Nogueira-Garcia, Mariana Alves, Fausto J Pinto, et al.
European Journal of Clinical Nutrition|December 9, 2022
Fish intake and risk of cardiovascular events: an analysis of the VITAL cohortDaniel Caldeira, Beatriz Nogueira-Garcia, Ana Abreu, et al.
European Journal of Internal Medicine|November 4, 2021
The high-risk bleeding category of different scores in patients with venous thromboembolism: Systematic review and meta-analysisMiguel Marques Antunes, Mariana Alves, Fausto J Pinto, et al.
Pharmacoepidemiology and Drug Safety|May 27, 2015
Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysisDaniel Caldeira, Nilza Gonçalves, Fausto J Pinto, et al.
Plos One|February 21, 2019
Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysisDaniel Caldeira, Daniela Alves, João Costa, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 21, 2015
Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-AnalysisDaniel Caldeira, Nilza Gonçalves, Joaquim J Ferreira, et al.
Pageof 33